A COMPARATIVE STUDY ON THE CONSEQUENCES OF EXPECTANT AND MEDICAL MANAGEMENT IN THE PATIENT HAVING UNRUPTURED TUBAL PREGNANCY

Main Author: Dr. Arslan Ahmed, Omer Farooq, Javeria Haroon
Format: Article
Bahasa: eng
Terbitan: , 2018
Subjects:
Online Access: https://zenodo.org/record/1494103
Daftar Isi:
  • Objective: The aim of this research is to compare medical and expectant management among the patients who had β-hcg 1000-3000 IU/L of unruptured-tubal pregnancy. Materials & Methods: The number of patients for this study was 82 with 18-40 years’ age, who had 1 to 3 thousand IU/L of the β-hcg level of tubal ectopic pregnancy. The study excluded patients with hetero-tropic pregnancy, non-tubal pregnancy, hypersensitivity to methotrexate, and ruptured ectopic. We made two groups (A: Expectant and B: medical management) through the lottery method. According to our research, if the level of β-hcg of a patient is less than 10 IU/L with pelvic-free fluid, adnexal absence, and gestational sac on ultra-sonography, measuring the result after two weeks, the process is successful. Results: The mean age of the women in group A and B was 30.9±5.95 and 30.65±6.37 years respectively. Gestational age (mean) was 07.12±02.12 and 07.63±02.41 weeks among the patients of group A and B respectively. Mean β-hcg level in group A and B was 1584.63 ± 515.81 and 1537.33 ± 519.68 IU/L. The mean β-hcg levels in group A was 1584.63±515.81 and in group, B was 1537.33±519.68 IU/L. The percentage of success in group A was 90.24 and group B was 63.4 with 0.004 p-values. Conclusion: Our study concludes that while dealing with tubal-ectopic pregnancy with β-hcg 1000 to 3000 IU/L, expectant management has more successful results. Keywords: Immuno-Assay, Intra-Uterine, Tubal, Fertilized, Expectant, Medical, Ovum, Laparoscopy.